In a 65‑year‑old man on postoperative day 13 after bilateral lung transplantation and coronary artery bypass grafting who has low serum albumin, high chest‑tube output, a negative fluid balance, and soft blood pressures, should albumin be continued and fluids in his total parenteral nutrition (TPN) be increased?

Albumin Should Be Discontinued in This Post-Transplant Patient

In this postoperative lung transplant patient with low blood pressures, albumin administration should be stopped and fluid resuscitation should rely on crystalloid solutions instead. The 2024 International Collaboration for Transfusion Medicine Guidelines explicitly recommend against using intravenous albumin for first-line volume replacement or to increase serum albumin levels in critically ill adult patients 1.

Why Albumin Is Not Indicated Here

The current approach violates evidence-based practice on multiple fronts:

• No mortality or morbidity benefit: Albumin does not improve patient outcomes compared to crystalloids in critically ill surgical patients. The SAFE trial (6,997 patients) and subsequent meta-analyses found no difference in 28-day mortality (RR 0.99; 95% CI 0.91-1.09) when comparing albumin to crystalloid resuscitation 1.

• Hypoalbuminemia is not an indication: Low serum albumin in the postoperative period (days 13 post-op) reflects inflammatory cytokine suppression and transcapillary loss—a normal physiologic response to major surgery 1. Giving albumin to "correct" this number does not improve outcomes and represents a fundamental misunderstanding of postoperative physiology.

• Potential harm in this population: Albumin can cause fluid overload, hypotension (paradoxically), hemodilution requiring transfusion, and peripheral gangrene from dilution of natural anticoagulants 1. In lung transplant patients specifically, avoiding positive fluid balance is critical to prevent pulmonary edema 2.

The Correct Approach to Hypotension Post-Transplant

Use buffered crystalloid solutions (lactated Ringer's or Plasma-Lyte) as first-line therapy for volume resuscitation 2. The 2024 perioperative fluid management guidelines recommend buffered crystalloids over 0.9% saline (98% agreement among experts) and explicitly recommend against routine albumin use (96% agreement) 2.

Key Management Principles:

1. Identify the cause of hypotension: Is this hypovolemia from chest tube losses, vasodilation from sepsis, cardiac dysfunction, or bleeding? Each requires different management.

2. Crystalloid resuscitation: Administer 250-500 mL boluses of buffered crystalloid, reassessing hemodynamics after each bolus. Target adequate perfusion markers (urine output >0.5 mL/kg/hr, lactate clearance, mental status).

3. Avoid fluid overload: In lung transplant patients, excessive fluid administration increases risk of primary graft dysfunction and pulmonary edema. Aim for neutral to slightly negative fluid balance after the first 24 hours post-transplant 2, 3.

4. Consider vasopressors early: If hypotension persists despite adequate volume replacement (typically 1-2 L crystalloid), initiate vasopressor support rather than continuing fluid administration 2.

Cost and Resource Considerations

Albumin costs approximately $130 per 25g vial 1—a significant expense with no demonstrated benefit in this clinical scenario. One study found 0% guideline compliance for albumin use in ICUs, resulting in substantial unnecessary costs 4. Discontinuing albumin here represents both better patient care and responsible resource stewardship.

Common Pitfalls to Avoid

• Don't treat the albumin number: Serum albumin <3.5 g/dL is expected post-operatively and does not require correction unless the patient has cirrhosis with specific complications (SBP, HRS, large-volume paracentesis) 1, 5, 6.

• Don't confuse oncotic pressure with volume status: While albumin is hyperoncotic and can pull fluid into the vascular space, this does not translate to improved outcomes and may worsen pulmonary edema in transplant patients 7.

• Don't continue ineffective therapy: If albumin hasn't stabilized blood pressure by now (day 13), it's not going to—reassess the underlying cause of hypotension rather than escalating an ineffective intervention.

Specific Recommendations for TPN Fluid Management

Increasing fluids in TPN is reasonable for addressing negative fluid balance, but:

• Calculate total daily fluid needs based on maintenance requirements plus ongoing losses (chest tube output)
• Monitor for signs of fluid overload (weight gain, pulmonary edema, pleural effusions)
• Coordinate TPN fluid content with other IV fluid sources to avoid excessive administration
• Consider concentrating TPN if fluid restriction becomes necessary

The evidence is clear and consistent: stop the albumin, use crystalloids for volume resuscitation, and focus on identifying and treating the underlying cause of hypotension 1, 2.